Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 14.41B | 14.73B | 13.78B | 14.16B | 12.91B | 13.01B |
Gross Profit | 3.56B | 3.73B | 3.37B | 3.42B | 3.08B | 3.28B |
EBITDA | 1.41B | 1.62B | 1.29B | 1.44B | 1.19B | 1.39B |
Net Income | 939.81M | 1.05B | 834.90M | 899.25M | 763.79M | 901.47M |
Balance Sheet | ||||||
Total Assets | 11.13B | 12.15B | 11.33B | 11.42B | 10.86B | 11.25B |
Cash, Cash Equivalents and Short-Term Investments | 2.71B | 3.92B | 3.93B | 1.45B | 913.26M | 569.20M |
Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities | 3.02B | 3.42B | 3.03B | 3.41B | 3.22B | 3.80B |
Stockholders Equity | 8.11B | 8.73B | 8.30B | 8.01B | 7.64B | 7.45B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 570.91M | 1.15B | 638.07M | 1.22B | -121.42M |
Operating Cash Flow | 0.00 | 692.50M | 1.23B | 822.74M | 1.33B | -7.17M |
Investing Cash Flow | 0.00 | -114.20M | -89.36M | -185.32M | -224.24M | -122.57M |
Financing Cash Flow | 0.00 | -590.64M | -628.15M | -544.42M | -800.57M | -627.04M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $9.27T | 17.42 | 11.81% | 2.26% | 6.06% | 3.97% | |
80 Outperform | $2.50T | 12.93 | 8.51% | 2.59% | 6.29% | 29.42% | |
75 Outperform | €2.13T | 23.49 | 24.26% | 1.71% | 22.46% | 78.58% | |
74 Outperform | €592.30B | 32.98 | 9.67% | 0.94% | -1.56% | 25.78% | |
71 Outperform | ¥254.22B | 13.37 | 8.49% | 3.04% | 6.33% | 12.89% | |
68 Neutral | ¥13.18B | 12.57 | 5.14% | 3.62% | -12.03% | ||
68 Neutral | $417.03B | 7.36 | 9.42% | 2.16% | 1.13% | 34.15% |